Identification of Novel Translational Urinary Biomarkers for Acetaminophen-induced Acute Liver Injury Using Proteomic Profiling in Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 21

PMID 23166697

Citations 7

Authors

Rachel P L van Swelm

Coby M M Laarakkers

Ellen C van der Kuur

Eva Morava-Kozicz

Ron A Wevers

Kevin D Augustijn

Daan J Touw

Maro H Sandel

Rosalinde Masereeuw

Frans G M Russel

Affiliations

Soon will be listed here.

Abstract

Drug-induced liver injury (DILI) is the leading cause of acute liver failure. Currently, no adequate predictive biomarkers for DILI are available. This study describes a translational approach using proteomic profiling for the identification of urinary proteins related to acute liver injury induced by acetaminophen (APAP). Mice were given a single intraperitoneal dose of APAP (0-350 mg/kg bw) followed by 24 h urine collection. Doses of ≥275 mg/kg bw APAP resulted in hepatic centrilobular necrosis and significantly elevated plasma alanine aminotransferase (ALT) values (p<0.0001). Proteomic profiling resulted in the identification of 12 differentially excreted proteins in urine of mice with acute liver injury (p<0.001), including superoxide dismutase 1 (SOD1), carbonic anhydrase 3 (CA3) and calmodulin (CaM), as novel biomarkers for APAP-induced liver injury. Urinary levels of SOD1 and CA3 increased with rising plasma ALT levels, but urinary CaM was already present in mice treated with high dose of APAP without elevated plasma ALT levels. Importantly, we showed in human urine after APAP intoxication the presence of SOD1 and CA3, whereas both proteins were absent in control urine samples. Urinary concentrations of CaM were significantly increased and correlated well with plasma APAP concentrations (r = 0.97; p<0.0001) in human APAP intoxicants, who did not present with elevated plasma ALT levels. In conclusion, using this urinary proteomics approach we demonstrate CA3, SOD1 and, most importantly, CaM as potential human biomarkers for APAP-induced liver injury.

Citing Articles

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques.

Guo K, van den Beucken T Cell Biosci. 2024; 14(1):134.

PMID: 39488681 PMC: 11531151. DOI: 10.1186/s13578-024-01317-2.

Integrative interactomics applied to bovine fescue toxicosis.

Mote R, Hill N, Skarlupka J, Carpenter J, Lourenco J, Callaway T Sci Rep. 2022; 12(1):4899.

PMID: 35318361 PMC: 8941056. DOI: 10.1038/s41598-022-08540-2.

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver Injury.

Kralj T, Brouwer K, Creek D Toxicol Sci. 2021; 183(1):1-13.

PMID: 34086958 PMC: 8502468. DOI: 10.1093/toxsci/kfab069.

[Establishment and validation of a neonatal pig model of hemolytic jaundice].

Li Y, Ma Y, Nie L, Chen S, Jin M, Wang S Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(5):431-4.

PMID: 27165593 PMC: 7390372.

Blood gene expression profiling of an early acetaminophen response.

Bushel P, Fannin R, Gerrish K, Watkins P, Paules R Pharmacogenomics J. 2016; 17(3):230-236.

PMID: 26927286 PMC: 5782799. DOI: 10.1038/tpj.2016.8.

References

Smyth R, Munday M, York M, Clarke C, Dare T, Turton J . Dose response and time course studies on superoxide dismutase as a urinary biomarker of carbon tetrachloride-induced hepatic injury in the Hanover Wistar rat. Int J Exp Pathol. 2009; 90(5):500-11. PMC: 2768148. DOI: 10.1111/j.1365-2613.2009.00666.x. View

Rumack B, MATTHEW H . Acetaminophen poisoning and toxicity. Pediatrics. 1975; 55(6):871-6. View

Jaeschke H, McGill M, Williams C, Ramachandran A . Current issues with acetaminophen hepatotoxicity--a clinically relevant model to test the efficacy of natural products. Life Sci. 2011; 88(17-18):737-45. PMC: 3076526. DOI: 10.1016/j.lfs.2011.01.025. View

Nicotera P, McConkey D, Jones D, Orrenius S . ATP stimulates Ca2+ uptake and increases the free Ca2+ concentration in isolated rat liver nuclei. Proc Natl Acad Sci U S A. 1989; 86(2):453-7. PMC: 286488. DOI: 10.1073/pnas.86.2.453. View

Yamamoto T, Tomizawa K, Fujikawa M, Sato Y, Yamada H, Horii I . Evaluation of human hepatocyte chimeric mice as a model for toxicological investigation using panomic approaches--effect of acetaminophen on the expression profiles of proteins and endogenous metabolites in liver, plasma and urine. J Toxicol Sci. 2007; 32(3):205-15. DOI: 10.2131/jts.32.205. View

Abbas K, Breton J, Drapier J . The interplay between nitric oxide and peroxiredoxins. Immunobiology. 2008; 213(9-10):815-22. DOI: 10.1016/j.imbio.2008.07.029. View

Tirmenstein M, Nelson S . Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. J Biol Chem. 1989; 264(17):9814-9. View

Agarwal R, Hennings L, Rafferty T, Letzig L, McCullough S, James L . Acetaminophen-induced hepatotoxicity and protein nitration in neuronal nitric-oxide synthase knockout mice. J Pharmacol Exp Ther. 2011; 340(1):134-42. PMC: 3251022. DOI: 10.1124/jpet.111.184192. View

Raisanen S, Lehenkari P, Tasanen M, Rahkila P, Harkonen P, Vaananen H . Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 1999; 13(3):513-22. DOI: 10.1096/fasebj.13.3.513. View

10.

Merrick B, Bruno M, Madenspacher J, Wetmore B, Foley J, Pieper R . Alterations in the rat serum proteome during liver injury from acetaminophen exposure. J Pharmacol Exp Ther. 2006; 318(2):792-802. PMC: 1892200. DOI: 10.1124/jpet.106.102681. View

11.

Tujios S, Fontana R . Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011; 8(4):202-11. DOI: 10.1038/nrgastro.2011.22. View

12.

Kentsis A . Challenges and opportunities for discovery of disease biomarkers using urine proteomics. Pediatr Int. 2010; 53(1):1-6. PMC: 4636200. DOI: 10.1111/j.1442-200X.2010.03253.x. View

13.

Banks A, ZIMMERMAN H, Ishak K, HARTER J . Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology. 1995; 22(3):820-7. View

14.

Abdelmegeed M, Moon K, Chen C, Gonzalez F, Song B . Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol. 2009; 79(1):57-66. PMC: 2784150. DOI: 10.1016/j.bcp.2009.07.016. View

15.

Visser K, van der Heijde D . Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol. 2010; 27(6):1017-25. View

16.

Vanhoutte K, Laarakkers C, Marchiori E, Pickkers P, Wetzels J, Willems J . Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Nephrol Dial Transplant. 2007; 22(10):2932-43. DOI: 10.1093/ndt/gfm170. View

17.

Bigelow D, Squier T . Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim Biophys Acta. 2005; 1703(2):121-34. DOI: 10.1016/j.bbapap.2004.09.012. View

18.

Stine J, Lewis J . Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol. 2011; 7(7):875-90. DOI: 10.1517/17425255.2011.577415. View

19.

Papale M, Pedicillo M, Thatcher B, Di Paolo S, Lo Muzio L, Bufo P . Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 856(1-2):205-13. DOI: 10.1016/j.jchromb.2007.06.001. View

20.

Ramachandran A, Lebofsky M, Weinman S, Jaeschke H . The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 2011; 251(3):226-33. PMC: 3050115. DOI: 10.1016/j.taap.2011.01.004. View